StockNews.com upgraded shares of Jaguar Health (NASDAQ:JAGX – Free Report) from a sell rating to a hold rating in a research note issued to investors on Friday morning.
Jaguar Health Stock Down 0.9 %
Shares of NASDAQ JAGX opened at $1.10 on Friday. Jaguar Health has a 1-year low of $0.95 and a 1-year high of $31.74. The company has a debt-to-equity ratio of 1.32, a current ratio of 2.10 and a quick ratio of 1.60. The business’s 50 day moving average is $1.83 and its two-hundred day moving average is $5.25.
Jaguar Health (NASDAQ:JAGX – Get Free Report) last announced its earnings results on Tuesday, August 13th. The biotechnology company reported ($4.04) EPS for the quarter, missing analysts’ consensus estimates of ($1.20) by ($2.84). Jaguar Health had a negative return on equity of 412.63% and a negative net margin of 350.18%. The company had revenue of $2.72 million during the quarter. As a group, analysts anticipate that Jaguar Health will post -0.78 earnings per share for the current fiscal year.
Institutional Investors Weigh In On Jaguar Health
Jaguar Health Company Profile
Jaguar Health, Inc, a commercial stage pharmaceuticals company, focuses on developing plant-based prescription medicines for people and animals with gastrointestinal distress, specifically chronic and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It focuses on developing and commercializing prescription and non-prescription products for companion and production animals; and human products.
Recommended Stories
- Five stocks we like better than Jaguar Health
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Powering Your Portfolio: The Utility Sector’s Electrifying Surge
- Compound Interest and Why It Matters When Investing
- Adobe Stock Builds Long-Term Value: Consider Buying on the Dip
- What is a buyback in stocks? A comprehensive guide for investors
- Albemarle Jumps as Lithium Stock Buying Frenzy Takes Off
Receive News & Ratings for Jaguar Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jaguar Health and related companies with MarketBeat.com's FREE daily email newsletter.